US 2015/0190481 A1Published application

Combination for treating an inflammatory disorder

AssigneeArthrogen B.V.

InventorJonathan D. Finn

Life of this patent

Estimating the term…

The invention provides a combination of a source of a CD39 and of a source of a CD73.

Dependent claims

1-21. (canceled)

Dependencies are inferred from the claim text.

A61K 38/465
Hydrolases: acting on ester bonds , e.g. lipases, ribonucleases
A61K 9/127
Dispersions; Emulsions: synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
A61K 38/46
Enzymes; Proenzymes; Derivatives thereof: hydrolases
C12N 9/14
Enzymes; Proenzymes; Compositions thereof ; Processes for preparing, activating, inhibiting, separating or purifying enzymes: hydrolases

From the US filing history. Foreign family members aren’t listed.

Loading patent…